Postpartum Visit Timing and the Effect on Visit Attendance

NCT ID: NCT05399784

Last Updated: 2023-08-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

162 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-02-01

Study Completion Date

2023-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to assess if the addition of an early postpartum visit improves attendance at postpartum visits. We seek to evaluate if an additional early postpartum visit improves patient education, satisfaction, or trust in the clinicians during the postpartum period; all of which may ultimately facilitate improved outcomes. Additionally, we seek to explore patient preferences for postpartum care delivery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Maternal mortality in the United States is currently at a record high of 17 deaths per 100,000 live births and the majority of pregnancy related deaths occur in the postpartum period due to complications from chronic disease exacerbation, pregnancy-related hypertension, or psychiatric conditions that lead to suicide. Optimal postpartum care would reduce mortality risk, but numerous studies have demonstrated current care is inadequate. Up to 40% of women do not attend their postpartum visit at 4-6 weeks after delivery and the 15-minute visit is too short to achieve the comprehensive goals that the American College of Obstetricians and Gynecologists (ACOG) sets for this visit: a full assessment of physical, social, and psychological well-being. In addressing the current gap between optimal and actual care, ACOG recently recommended that practitioners shift from the standard, single six-week postpartum visit to two postpartum visits, the first within three weeks of delivery. While this change is intended to address current sub-optimal outcomes, the effects of this change are entirely unknown.

The long term goal of our program is to improve postpartum care for women in Rhode Island. The primary objective of this project is to determine if the ACOG proposed additional postpartum visit within three weeks of delivery improves attendance to postpartum appointments compared to routine postpartum care. Additionally, we intend to examine whether having two scheduled postpartum visits (one within three weeks and the other at the standard 4-6 week postpartum time point) which we describe as "early and often" postpartum care-improves patient knowledge, satisfaction and trust in clinicians compared to routine care as well as explore patient preferences for postpartum care. Our central hypothesis is that early and often postpartum care will lead to improved patient visit attendance compared to routine care.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postpartum Disorder Postpartum Depression Postpartum Weight Retention Breastfeeding Satisfaction, Patient Trust

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Early & Often Postpartum Care

Visit at 2-3 and 6 weeks postpartum.

Group Type EXPERIMENTAL

Early postpartum visit

Intervention Type BEHAVIORAL

The early postpartum visit will be an in-person visit with a medical provider at 14-21 days postpartum.

Standard postpartum visit

Intervention Type BEHAVIORAL

The standard postpartum visit will occur at 35 to 56 days postpartum.

Standard Postpartum Care

Visit at 6 weeks postpartum.

Group Type PLACEBO_COMPARATOR

Standard postpartum visit

Intervention Type BEHAVIORAL

The standard postpartum visit will occur at 35 to 56 days postpartum.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Early postpartum visit

The early postpartum visit will be an in-person visit with a medical provider at 14-21 days postpartum.

Intervention Type BEHAVIORAL

Standard postpartum visit

The standard postpartum visit will occur at 35 to 56 days postpartum.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age 13 to 50 years old
* literacy in English or Spanish
* receipt of prenatal care at the Obstetrics and Gynecology Care Center of Women \& Infants Hospital
* delivery at Women \& Infants Hospital during the study time period

Exclusion Criteria

High risk pregnancy defined as one or more of the following:

* chronic hypertension
* gestational hypertension
* preeclampsia
* eclampsia
* third degree perineal laceration
* fourth degree perineal laceration
* blood product transfusion
* intensive care unit admission
* who were prescribed anxiolytic or antidepressant medications in the antepartum period
Minimum Eligible Age

13 Years

Maximum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Women and Infants Hospital of Rhode Island

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Martha B Kole-White, MD

Role: PRINCIPAL_INVESTIGATOR

Women & Infants Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Women & Infants Hospital

Providence, Rhode Island, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Kole_ConstanceHowesGrant_2020

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Navigating New Motherhood 2
NCT03922334 COMPLETED NA